RetroVirox Inc. Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
RetroVirox Inc. is a privately held contract research organization focused exclusively on virology, offering a broad range of antiviral and neutralization assays on a fee-for-service or fixed-term engagement basis. Its services include in vitro infectivity, replication, and neutralization assays to assess antiviral activity of experimental drugs and to evaluate candidate vaccines and antibodies, with testing available against more than a dozen viruses and optional customization such as generating drug-resistant viral strains. The company serves a diverse customer base that includes startups, biotech firms, and larger pharmaceutical companies across more than 20 countries on five continents, addressing preclinical discovery needs in virology and supporting multiple programs that reach FDA approval. Based in San Diego, California, RetroVirox operates as a specialized provider within the biotechnology research industry, positioning itself as a focused partner for antiviral, neutralization, and vaccine testing services. A recent development noted is the company’s expansion of cell-based antiviral services to evaluate therapies and vaccines against coronaviruses, including SARS-CoV-2.